“In most assessments of AD, researchers used genome-wide association studies (GWAS), which are observational tests that look at all of the genetic information within DNA to find connections. However, GWAS does not catch the risk from rare variants of mutations. […]
“Its residents can come and go from their homes as they please, whether through the unlocked door or through a window. They can wake and shower at their leisure; they can shout, pilfer sweets, make tea at 2 a.m., sweep […]
“The international team, led by the University of Cambridge, found that instead of starting from a single point in the brain and initiating a chain reaction that leads to the death of brain cells, Alzheimer’s disease reaches different regions of […]
Don’t let the big words scare you off. This is an insightful analysis of the FDA’s recent approval of a new Alzheimers drug from Scott Alexander. Conclusion: unbundle the FDA! | learn more
The most widespread theory is that a type of plaque builds up in the brain to cause Alzheimer’s, but no treatments to remove the plaque have shown good outcomes fighting the disease. Maybe the plaque is an immune response to […]
“A provocative new study is suggesting the same bacteria responsible for gum disease is also the primary pathogenic cause of Alzheimer’s disease. Not only that, but a new drug developed to inhibit these bacterial toxins and treat Alzheimer’s is moving […]